...
首页> 外文期刊>Journal of Clinical Microbiology >Carbapenem Heteroresistance in VIM-1-Producing Klebsiella pneumoniae Isolates Belonging to the Same Clone: Consequences for Routine Susceptibility Testing
【24h】

Carbapenem Heteroresistance in VIM-1-Producing Klebsiella pneumoniae Isolates Belonging to the Same Clone: Consequences for Routine Susceptibility Testing

机译:VIM-1生产肺炎克雷伯氏菌分离物中的碳青霉烯异抗性属于同一克隆:常规药敏试验的结果

获取原文
           

摘要

Susceptibility results with low reproducibility by the same or different methods have been observed for metallo-beta-lactamase (MBL)-producing Enterobacteriaceae. Eighteen VIM-1-producing Klebsiella pneumoniae isolates (one per patient) belonging to a single epidemic clone in our hospital (2005 to 2008) but with different susceptibilities to carbapenems were studied. Imipenem MICs ranged from 8 to >128 mg/liter by standard CLSI microdilution, from ≤1 to >8 mg/liter by the semiautomatic Wider system, and from 0.75 to >32 mg/liter by Etest. Meropenem MICs ranged from 0.5 to 128, ≤1 to >8, and 0.38 to >32 mg/liter, respectively. Ertapenem MICs by CLSI microdilution and Etest ranged from 1 to 64 and 0.75 to >32 mg/liter, respectively. The rates of essential agreement (±1 log2 dilution) for imipenem and meropenem MICs between the Wider system and the reference microdilution method were 45% and 49%, respectively. Those between Etest and the reference microdilution method for imipenem, meropenem, and ertapenem MICs were 33%, 67%, and 84%. The rates of very major errors for the Wider system and Etest were 33% and 28% for imipenem and 25% and 75% for meropenem, respectively. Low MIC reproducibility was observed even when the same inoculum was used (differences up to 4-fold dilutions). Heteroresistance was suspected due to the presence of colonies in the Etest inhibition zone. It was confirmed by population analysis profiles of 4 isolates displaying different imipenem MICs, with the exception of an OmpK36-porin-deficient isolate that homogeneously expressed carbapenem resistance (MIC, >128 mg/liter). Low carbapenem MIC reproducibility could be due to the presence of resistant subpopulations and variable expression of the resistance mechanisms. Since carbapenem MICs are not good markers of MBL production, reliable and reproducible phenotypic methods are needed to detect the presence of this mechanism.
机译:对于生产金属β-内酰胺酶(MBL)的肠杆菌科,已通过相同或不同方法观察到了低重复性的药敏结果。我们医院(2005年至2008年)研究了18个VIM-1产生性肺炎克雷伯菌肺炎克雷伯菌(每例患者一个),它们属于单个流行克隆,但对碳青霉烯类药物的敏感性不同。通过标准CLSI微稀释,亚胺培南MIC的范围从8到> 128 mg / L,通过半自动Wider系统从≤1到> 8 mg / L,从Etest到0.75到> 32 mg / L。美洛培南的MIC范围分别为0.5至128,≤1至> 8和0.38至> 32 mg / L。通过CLSI微稀释和Etest测定的Ertapenem MIC分别为1至64和0.75至> 32 mg / L。在Wider系统和参考微量稀释方法之间,亚胺培南和美罗培南MIC的基本一致性(±1 log 2 稀释率)分别为45%和49%。在Etest和亚胺培南,美洛培南和厄他培南MIC的参考微量稀释方法之间的MIC分别为33%,67%和84%。 Wider系统和Etest的主要错误率分别为亚胺培南33%和28%,美罗培南25%和75%。即使使用相同的接种物,MIC的重现性也很低(稀释度最高可达4倍)。由于Etest抑制区中存在菌落,因此怀疑存在异抗性。通过显示不同亚胺培南MIC的4个分离株的群体分析谱证实了这一点,但OmpK36-孔蛋白缺陷型分离株均均表现出碳青霉烯抗性(MIC,> 128 mg / L)。碳青霉烯MIC的低再现性可能是由于存在耐药性亚群和耐药机制的可变表达。由于碳青霉烯MIC并不是MBL产生的良好标志,因此需要可靠且可重现的表型方法来检测这种机制的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号